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had a honeycomb-patterned surface that faced the subconjunctival Tenon tissue and the other side 
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adjunctive treatment or 0.4 mg/ml mitomycin C (MMC; n=6 each). Intraocular pressure (IOP) 
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for 28 days after surgery followed by histological observation.
Results. Postoperative IOPs of the film-treated eyes were significantly lower than that of control 
eyes from day 10 to day 28 (P<0.05), but were not significantly different from those of MMC-treated 
eyes. The subconjunctival filtration space, detected by ultrasound biomicroscopy, disappeared in 
five control eyes, one MMC-treated eye, but none of the film-treated eyes. A bleb leak occurred 
postoperatively in two MMC-treated eyes. Histologically, in eyes without filtration surgery, fibrotic 
tissue with the film partly attached to it was noted on the honeycomb side, but was minimal on the 
sclera that faced the smooth side of the film. In eyes with filtration surgery, the honeycomb-
patterned film lined the inner bleb wall with minimal inflammatory reaction.
Conclusions. The thin honeycomb-patterned film that attached to the inner bleb wall worked as an 
adhesion barrier in glaucoma filtration surgery in rabbits, which is worthy of further investigation.
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Abstract
Purpose. To evaluate the effectiveness and safety of a thin 
honeycomb-patterned biodegradable film for glaucoma filtration surgery in 
rabbits.
Methods. A 7μm-thick film made from poly(L-lactide-co-ε-caprolactone) was 
placed in the subconjunctival space in one eye of rabbits, with or without 
full-thickness filtration surgery. The film had a honeycomb-patterned surface that
faced the subconjunctival Tenon tissue and the other side was smooth. Filtration 
surgery was also performed in the fellow eye, which received either no 
adjunctive treatment or 0.4 mg/ml mitomycin C (MMC; n=6 each). Intraocular 
pressure (IOP) measurements and bleb evaluations using ultrasound
biomicroscopy were performed periodically for 28 days after surgery followed by
histological observation.
Results. Postoperative IOPs of the film-treated eyes were significantly lower 
than that of control eyes from day 10 to day 28 (P<0.05), but were not 
significantly different from those of MMC-treated eyes. The subconjunctival 
filtration space, detected by ultrasound biomicroscopy, disappeared in five 
control eyes, one MMC-treated eye, but none of the film-treated eyes. A bleb 
leak occurred postoperatively in two MMC-treated eyes. Histologically, in eyes 
without filtration surgery, fibrotic tissue with the film partly attached to it was 
noted on the honeycomb side, but was minimal on the sclera that faced the 
smooth side of the film. In eyes with filtration surgery, the honeycomb-patterned 
film lined the inner bleb wall with minimal inflammatory reaction.
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Conclusions. The thin honeycomb-patterned film that attached to the inner bleb 
wall worked as an adhesion barrier in glaucoma filtration surgery in rabbits, 
which is worthy of further investigation.
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Introduction
Success of filtration surgery depends mostly on suppression of 
postoperative scarring around the filtration site. Although anti-scarring agents,
such as mitomycin C (MMC) and 5-fluorouracil (5-FU), help prevent 
postoperative scarring and improve glaucoma surgical outcomes, 1-7 their use 
has been associated with undesirable side effects, such as scleral ischemia,
hypotony, corneal problems, endophthalmitis, filtering bleb dysesthesia and 
cataract. 8-13 Recently, to avoid such postoperative complications caused by 
MMC and 5-FU, various anti-scarring chemicals and mechanical adhesion
barriers have been used in glaucoma filtration surgery in animal models. 14-31
Although favorable results were reported, no alternative methods to MMC or 
5-FU treatment have been widely adapted until now.
A honeycomb-patterned film is a thin biodegradable film made from 
poly(L-lactide-co-ε-caprolactone).32 It has a honeycomb structure that allows
tissue attachment on one side and a smooth structure that prevents adhesion on 
the other side. Therefore, the film can stick to the tissue surface on the 
honeycomb side, while preventing adhesion of other tissues to the smooth side. 
Recently, Narita et al 33 reported that this film prevented wound adhesion in a 
dog model of cardiac surgery. Therefore, this film, when attached to the 
subconjunctival Tenon tissue on the honeycomb side, may work as an adhesion 
barrier on the smooth side and prolong bleb survival after glaucoma filtration 
surgery. The purpose of this pilot study was to investigate the effectiveness and 
safety of a honeycomb-patterned film in an animal model of glaucoma filtration 
surgery.
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Materials and Methods
Fourteen New Zealand White rabbits (weight range, 2.5 kg to 3.0kg) 
were used. All procedures involving animals were performed according to the 
Association for Research in Vision and Ophthalmology statement for the Use of 
Animals in Ophthalmic and Vision Research. Experimental procedures were 
approved by the Committee on Animal Experimentation of Kanazawa University, 
Takara-machi campus, Japan. 
Surgery was performed on both eyes of all rabbits and all surgeries were 
performed by the same surgeon (T.O). The bilateral surgery protocol was
adapted because different rabbits had significantly different baseline IOPs and 
wound-healing reactions. Surgical procedures performed unilaterally as a 
preliminary experiment caused no serious postoperative complications (data not 
shown).
The Honeycomb-Patterned Film
The honeycomb-patterned film used in this study was about 7 μm thick,
biodegradable and made from poly(L-lactide-co-ε-caprolactone) (Fig. 1). Briefly, 
poly(L-lactide-co-ε-caprolactone) was dissolved in chloroform at a concentration 
of 5 mg/ml at room temperature. A surfactant, dioleoylphosphatidylethanolamine
(0.5% w/v), was added based on the weight of poly(L-lactide-co-ε-caprolactone). 
The honeycomb-patterned films were fabricated by simply casting under a 
current of highly humid air. 32
The film has a unique surface structure, characterized by pores of a 
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hexagonal shape interconnecting horizontally along the film surface on one side. 
The opposite side of the film is quite smooth. 32 This honeycomb structure has a
considerable influence on the adhesion, migration and proliferation of cells and 
the opposite smooth side prevents adhesion of the wound following surgical 
treatments. 32 Dissolution time of the film depends on the size and thickness of 
the film and the proportion of poly(lactic acid) to polycaprolactone. The film used 
in this study consisted of approximately 88% poly(lactic acid) and 12% 
polycaprolactone. It took approximately one year before a comparable film 
dissolved in dry tissue (unpublished data from Teijin Corporation).
Subconjunctival Placement of the Honeycomb-Patterned Film without
Filtration Surgery
Prior to experimental filtration surgery, we examined the effect of film
that was placed in the subconjunctival space. Two rabbits were used. The 
rabbits were anesthetized with an intramuscular injection of ketamine 
hydrochloride (35 mg/kg) and xylazine hydrochloride (5 mg/kg). An eyelid 
speculum was inserted and the eye was fixed with a corneal traction suture (8-0 
vicryl; Ethicon, Piscataway, NJ). After a conjunctival incision 8 mm from the 
limbus, the sclera was exposed anteriorly to the limbus in both eyes. The 
honeycomb-patterned film, 6×6 mm2, was sutured with 10-0 nylon on the sclera
in one eye, with the honeycomb side facing up. Nothing was placed in the fellow
eye (control). The conjunctival wound was closed with a running 10-0 nylon 
suture. Postoperative examination with slit-lamp biomicroscopy and indirect 
ophthalmoscopy was performed for 4 weeks. Subsequently, all rabbit eyes were 
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subjected to histological evaluation.
Filtration Surgery Procedure
Twelve rabbits were randomly assigned to one of two groups (6 rabbits
in each group). The filtration site of one eye received the honeycomb-patterned 
film, while that of the fellow eye was treated as follows: no adjunctive treatment
(group 1) or MMC (group 2). In order to minimize the subjective bias regarding 
the surgical procedure, the operation was started in one eye and it was after 
creation of the scleral flap that the eye was randomly assigned the 
honeycomb-patterned film or not. Also, the dimension of the scleral flap and the 
sclerostomy was strictly checked by an assistant surgeon (T. H) during the 
surgery.
Rabbits were anesthetized with an intramuscular injection of ketamine 
hydrochloride (35 mg/kg) and xylazine hydrochloride (5 mg/kg). An eyelid 
speculum was inserted and the eye was fixed with a corneal traction suture (8-0 
vicryl). The conjunctiva in the superior-nasal quadrant was incised 8 mm from 
the limbus and was carefully dissected anteriorly to the limbus. Then a 3×3 mm 
partial-thickness scleral flap was outlined. For the MMC-treated eyes (group 2), 
a surgical sponge measuring 5×5 mm was cut and soaked in 0.4 mg/ml MMC 
(Kyowa Hakko Kogyo Co, Tokyo, Japan). It was placed on the sclera, under the
conjunctival flap, for 3 minutes. After MMC application, this area was irrigated
thoroughly with balanced salt solution (BSS; Santen Pharmaceutical Co., Ltd., 
Osaka, Japan). A sclerostomy (1×2 mm) was performed under the scleral flap 
using a Kelly Descemet’s membrane punch and the scleral flap was then 
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dissected. For the honeycomb-patterned film placement (all groups), a piece of 
film (6×6 mm) was placed on the sclerostomy site. The film, turned honeycomb 
side toward the subconjunctival Tenon tissue, was loosely secured by suturing
on the sclera with 10-0 nylon at the two corners near the limbus and at the center
of the two corners on the fornix side (Fig. 2). A peripheral iridectomy was not 
performed to avoid bleeding and the conjunctival incision was closed with a 
running 10-0 nylon suture. After surgery, a subconjunctival injection of steroid (1
mg of triamcinolone: Kenakolot-A; Bristol Pharmaceuticals KK, Tokyo, Japan) 
was performed away from the filtration site to decrease postoperative 
inflammation, and ofloxacin ointment (Santen, Pharmaceutical Co., Ltd., Osaka, 
Japan) was applied.
Preoperative and Postoperative Examinations
After topical anesthesia of 0.4% oxybuprocaine hydrochloride (Santen 
Pharmaceutical Co., Ltd., Osaka, Japan), IOP was measured using a Tonopen 
(Mentor, Norwell, MA) at baseline and 3, 7, 10, 14, 17, 21, 24 and 28 days after 
surgery. IOP measurements were conducted in a masked fashion. IOP was 
measured three times per eye and a mean reading was documented, except if 
the confidence interval was less than 95%. Under the general anesthesia 
described above, the conjunctiva, cornea, and anterior segment of each eye 
were recorded with a digital video (GVD-1000; SONY CO., Tokyo, Japan) under 
a surgical microscope following postoperative IOP measurements. Thereafter, 
ultrasound biomicroscopy (UBM; UD-6000, Tomey, Nagoya, Japan) was 
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performed to examine blebs. At the end of the examination, each eye received 
levofloxacin eye drops (Santen Pharmaceutical Co., Ltd., Osaka, Japan). 
Animals were examined at specified intervals for 28 days after surgery 
followed by histological evaluation. 
Histological Evaluation
Animals were killed on day 28 by an overdose intravenous injection of 
sodium pentobarbital under deep general anesthesia. Corneoscleral blocks of 
the operation site (10×10 mm2) with overlying conjunctiva were dissected from 
all eyes. All blocks were fixed in 20% paraformaldehyde and embedded in 
paraffin. Sections through the center of the operation site were stained with 
hematoxylin and eosin (H&E) and observed by light microscopy. Histological 
evaluations were conducted in a masked fashion regarding the surgical 
procedures.
Statistical Evaluation
In eyes that received filtration surgery, comparison of IOP between 
fellow eyes was performed using the paired t-test. Presence of filtration space 
detected by UBM on day 28 was compared between film-treated and fellow eyes 
by the χ2 test. For all analyses, P-values less than 0.05 were considered 
statistically significant.
Results
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Subconjunctival Placement of the Honeycomb-patterned Film without 
Glaucoma Filtration Surgery
In honeycomb-patterned film-treated eyes, no significant inflammatory 
findings were observed in the follow-up period; that is, the anterior segment was 
silent and the conjunctiva and sclera were not remarkably injected as observed
for control eyes. Histopathologically, several multinucleated macrophages were 
observed but foreign body granuloma formation was not detected. Lymphoid or 
neutrophil infiltration in the subconjunctival space was minimal in both the 
film-treated and control eyes (Fig. 3A, C). In the film-treated eyes, fibrotic tissue 
with the film partly attached to it was noted on the honeycomb side of the film, 
but was minimal on the scleral side, which faced the smooth side of the film (Fig.
3A, B). In control eyes, fibrotic tissue was observed on the sclera (Fig. 3C).
Intraoperative Administration of the Honeycomb-patterned Film Compared 
with No Treatment or MMC in Glaucoma Filtration Surgery
Postoperative IOP changes 
Mean IOP was significantly lower than baseline until day 28 in 
honeycomb-patterned film-treated and MMC-treated eyes. In group 1, the IOP of 
honeycomb-patterned film-treated eyes was significantly lower than that of 
control eyes from day 10 to day 28 (P<0.05; Fig. 4A). Postoperative IOPs of the
film-treated eyes were not significantly different from MMC-treated eyes (Fig. 
4B).
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Surgical Microscope Examinations 
No eyes exhibited severe postoperative inflammation in the anterior 
chamber. All corneas stayed clear and no blebitis or endophthalmitis was 
observed during the postoperative period. The degree of conjunctival injection,
which was observed during days 3 to 14 and decreased thereafter, was similar 
among control, honeycomb-patterned film-treated and MMC-treated eyes. Five
out of 6 MMC-treated blebs became totally and persistently avascular by days 7 
to 14. Among the avascular blebs, two MMC-treated blebs had transconjunctival 
aqueous leakage from days 21 to 24. Bleb leak and secondary hypotony 
continued until day 28. All 12 eyes treated with the honeycomb-patterned film 
had no bleb leak.
Bleb Appearance Examined by UBM
The subconjunctival filtration space after filtration surgery was monitored 
by UBM. Disappearance of the filtration space occurred in five of 6 control eyes
(group 1), one of 6 MMC-treated eyes (group 2), but none of the 12 film-treated 
eyes (groups 1 and 2). At day 14, 67% of control eyes had no filtration space.
The timing of the disappearance of the filtration space was almost coincident
with an IOP increase to baseline level. On day 28, the presence of the filtration 
space in film-treated eyes was significantly more frequent than that of control 
eyes (P<0.05), but not significantly different from that of MMC-treated eyes. In 
film-treated eyes, a septum that suggested the presence of the film was imaged 
by UBM (Fig. 5). Various blebs of large, flat and normal size were observed early 
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in the postoperative period in the film-treated eyes (Figs. 6A, B). However, all of 
the flat-looking blebs became spontaneously elevated later (Fig. 6C).
Histopathological Features
The degree of subconjunctival fibrotic response in the surgical area was 
similar among control and honeycomb-patterned film treated eyes, but was 
markedly suppressed in MMC-treated eyes by H&E staining (Fig. 7). The 
conjunctiva of the bleb area appeared normal in all control and
honeycomb-patterned film-treated eyes, but was disrupted in eyes with 
avascular blebs in 5 of 6 MMC-treated eyes. Severe inflammation was absent in 
all eyes and no signs of toxicity to the surrounding ocular tissues were observed 
in honeycomb-patterned film treated eyes. The film lined the inner bleb wall with 
minimal inflammatory reactions.
Discussion
In this study, the use of a honeycomb-patterned film appeared to 
promote IOP reduction and bleb survival in glaucoma filtration surgery in rabbits.
In addition, no obvious intraoperative or postoperative complications were noted
using the film. Although MMC-treated eyes had a similar postoperative IOP 
decrease to honeycomb-patterned film-treated eyes, avascular bleb formation 
and transconjunctival aqueous leakage were found postoperatively in some 
eyes. Histology showed a marked suppression of the postoperative fibrotic 
response and disruption of the conjunctival epithelium in MMC-treated eyes as 
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reported previously. 34 In contrast, the film-treated eyes showed no abnormalities
in the conjunctival epithelium.
Inhibition of wound adhesion in glaucoma filtration surgery to promote 
bleb survival can be classified as anti-scarring chemicals or mechanical 
adhesion barriers. Anti-scarring chemicals that have recently been tested in 
experimental glaucoma filtration surgery include inhibitors or antibodies against
transforming growth factor, 14, 15 an antibody against connective tissue growth 
factor 15 an antibody against matrix metalloproteinase inhibitor, 16, 17 matrix 
metalloproteinase-3 , cyclosporine, 18 bleomycin, 19 suramin, 20, 21
Rho-associated protein kinase inhibitor, 22 p21WAF-1/Cip-1, 23 fluorescence 
generated photoreaction products 24 and methylcellulose. 25 Amniotic membrane 
transplantation, which showed suppression of wound healing in experimental 
filtration surgery in agreement with its ability to down regulate TGFß signaling, 26
may also have a space-keeping effect as a mechanical barrier.
As for mechanical barriers, Gelfilm, an absorbable film made from pig 
gelatin, was the first to be used experimentally and also clinically in 1955, 27 but 
was later found to cause severe inflammation when put in the anterior chamber.
28 More recently, Interceed, an oxidated regenerated cellulose, and Seprafilm, a 
polymer film made from sodium hyaluronate and carboxymethylcellulose, which
are in clinical use for prevention of adhesions in gynecological and abdominal 
surgery, were tested for experimental glaucoma filtration surgery, but failed to 
show effectiveness. 29 Cross-linked hyaluronate hydrogel 30 and a small disk 
made of a biodegradable, porous collagen matrix were reported to promote 
postoperative IOP reduction compared to control eyes in experimental filtration 
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surgery. As a non-reabsorbable barrier, expanded polytetrafluoroethylene has 
been successfully used in trabeculectomy in human eyes. 31 Compared to other 
adhesion barriers, the distinguishing features of the honeycomb-patterned film 
are the unique surface structure on one side and its thinness. Our results 
suggest that the honeycomb-patterned surface caused different cellular 
reactions from the flat surface, which helped the film attach to the
subconjunctival Tenon tissue. Furthermore, the 7 μm thickness of the film, which 
may not have a significant space-keeping effect in contrast to the much thicker 
materials used in other reports, was found to be sufficient for an adhesion 
barrier. Even though the material is reabsorbable, a thinner adhesion barrier 
may cause less traumatic effects to the overlying conjunctiva. 
Although the honeycomb-patterned film (30 mm in diameter) was used 
without suturing in experimental cardiac surgery, 33 the film was sutured onto the 
sclera in this study so that it stayed precisely in the desired area because the 
size of the film was small (6x6 mm) and the subconjunctival space is highly 
mobile concomitantly with eye movements. The honeycomb-patterned film was 
attached to the subconjunctival Tenon tissue by allowing formation of fibrotic 
tissue on the honeycomb side when it was placed in the subconjunctival space 
without filtration surgery. After filtration surgery in a typical case, the film 
successfully attached to the Tenon tissue early in the postoperative period but in 
some cases, the film did not attach to it. This result suggests that over-filtration 
early in the postoperative period may prevent the film from attaching to the 
Tenon tissue. Although postoperative bleb size did not influence bleb survival, a 
more adhesive honeycomb design, which allows the film to attach to the Tenon 
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tissue more securely, may be desirable. In contrast, the smooth side of the film 
worked as a mechanical adhesion barrier between the subconjunctival Tenon 
tissue and the sclera, given that all of the flat-looking blebs observed early in the 
postoperative period in some film-treated eyes became spontaneously elevated 
afterwards.
Recently, UBM has been widely used to evaluate filtering blebs after 
glaucoma filtration surgery. 35 However, there have been no reports of bleb 
observation by UBM in animal models. In this study, UBM successfully showed 
the subconjunctival filtration space, even in a flat-looking bleb, and a septum,
which suggested the presence of the honeycomb-patterned film. Therefore, 
UBM may be useful to evaluate blebs in animal models of glaucoma filtration 
surgery.
In conclusion, a thin, honeycomb-patterned film attached to the inner
bleb wall worked as an adhesion barrier in glaucoma filtration surgery in rabbits.
The effect on postoperative IOP reduction and bleb survival was comparable to
that of MMC-treated eyes. This treatment may decrease the risk of serious 
postoperative complications of filtration surgery frequently found with MMC use,
such as bleb leakage and bleb infection. Further studies are needed to optimize 
film design regarding the honeycomb size, dissolution and absorption time, and 
to determine the potential use of the honeycomb-patterned film as an adhesion 
barrier in glaucoma filtration surgery.
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Legends
Figure 1. A scanning electron microscope image of the surface structure of the 
honeycomb-patterned film. The pore size is approximately 5 μm in diameter.
This characteristic structure enables it to attach to the tissue without glue. 
(Original magnification: × 5,000).
Figure 2. Schema of the surgical procedures used to place the
honeycomb-patterned film. 10-0 nylon suture (black arrow); the 
honeycomb-patterned film (arrow head); filtration site (white arrow); the area of 
dissected scleral flap (dashed line); the conjunctival incision line (asterisks).
Figure 3. Histopathological features of the effects of the honeycomb-patterned 
film on the sclera. A: control eye; B: honeycomb-patterned film-treated eye; C: 
higher magnification of B. Several multinucleated macrophages were observed, 
but foreign body granuloma formation was not detected. Lymphoid or neutrophil 
infiltration in the subconjunctival space was minimal in both film-treated and 
control eyes. In the film-treated eye, fibrotic tissue (asterisks) was noted on the 
honeycomb side of the film (arrows), between the subconjunctival Tenon tissue 
and the film, but was minimal on the smooth side of the film, between the film 
and the sclera. At a higher magnification, the honeycomb structure of the film
(arrows), which was partly attached to the fibrotic tissue, was observed. In a
control eye, fibrotic tissue was observed on the sclera. T: subconjunctival Tenon 
tissue; S: sclera. Sections were stained with hematoxylin and eosin. (Original 
magnification: A × 200; B × 200; C × 1000).
Figure 4. IOP changes over time in group 1 (A) and group 2 (B).The mean IOP 
in honeycomb-patterned film-treated eyes in group 1 was significantly lower than 
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that of control eyes in group 1 from day 10 to day 28 (*P<0.05). There was no 
significant difference in the mean IOP between honeycomb-patterned 
film-treated and MMC-treated eyes in group 2.
Figure 5. Typical bleb appearance of honeycomb-patterned film-treated eyes on 
postoperative day 3 (A, C) and day 28 (B, D). A, B: photographs taken with a 
surgical microscope. A mildly elevated diffuse bleb remained throughout the 
experimental period. Conjunctival injection noted on postoperative day 3
gradually disappeared. C, D: images of ultrasound biomicroscopy. A large 
filtration space (asterisks) with a septum, which suggested the presence of the 
honeycomb-patterned film (dashed lines), was observed. The film attached to 
the subconjunctival Tenon tissue anteriorly.
Figure 6. Various bleb appearances of honeycomb-patterned film-treated eyes 
at early postoperative periods. A large bleb (A) and a flat-looking bleb (B) on 
postoperative day 7. The honeycomb-patterned film did not attach to the 
subconjunctival Tenon tissue in the large bleb. The flat-looking bleb became 
spontaneously elevated afterwards (day 28: C) and the honeycomb-patterned 
film attached to the subconjunctival Tenon tissue. Arrows point to septa, which 
suggest the presence of the honeycomb-patterned film.
Figure 7. Histopathological features of the surgical area in eyes with blebs and 
IOP reduction. A: control eye, B: honeycomb-patterned film-treated eye, C: 
MMC-treated eye with no bleb leak, D: MMC-treated eye with bleb leak. The 
cornea is toward the right side in each photo. Asterisks indicate the 
subconjunctival filtration space. Arrows point to the conjunctival epithelium. The 
degree of subconjunctival fibrotic response was similar among control and 
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honeycomb-patterned film-treated eyes, but was markedly suppressed in 
MMC-treated eyes. The conjunctival epithelium of the bleb area appeared 
normal in control (A) and honeycomb-patterned film-treated eyes (B), but was 
attenuated in the MMC-treated eye with no bleb leak (C). In addition, a 
conjunctival epithelial defect was observed in the MMC-treated eye with bleb 
leak (D). Honeycomb-patterned film lining the inner bleb wall was observed 
(black arrow in B). Sections are stained with hematoxylin and eosin. (Original 
magnification: A × 100; B × 100; C × 100; D× 50).
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Response to comments
To the reviewer 1:
1. I would like to see the MMC concentration included in the abstract and 
an expanded legend for figure 4 which I found confusing.                                                                                                          
Reply: We added the concentration of MMC (0.4 mg/ml) to the abstract of the 
revised manuscript (page 2, line 10). The legend for figure 4 was changed to 
avoid confusion (page 21, lines 2 – 3). We also added “group 1” and “group 2” to
figure 4A and 4B, respectively, in the revised manuscript.
To the reviewer 2:
1. Figure 2 – a white arrowhead unaccounted for in the figure legend.                               
Reply: A white arrowhead was not necessary for figure 2, and it was deleted in 
the revised manuscript. The white arrow remains and depicts the filtration site, 
which is stated in the legend.
2. Figure 3 – It appears Figure 3 may be out of order.
Reply: We are very sorry for this careless mistake. We corrected the legend of 
figure 3 in the revised manuscript (page 20, lines 11 – 12 and line 22).
3. Figure 7 –
More labels are needed to orient the viewer in A. 
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Reply: We added more labels (asterisks and arrows) to figure 7 in the revised 
manuscript.
B appears to show a ruptured lens capsule or Descemet’s・・
Reply: As pointed out by the reviewer, it was actually a ruptured lens capsule. It 
was not an intraoperative or postoperative complication, but was ruptured when
the corneoscleral block was dissected from the eye for histological evaluation.
Because we do not think it is important to show the lens capsule in the figure, we 
took another photo omitting the lens capsule and made a new figure.
C does not appear to show the bleb wall – due to leaking one assumes? 
An intact MMC bleb may serve as a better comparison to 7B.                                                 
Reply: Figure 7C shows a conjunctival epithelial defect in the eye with a bleb 
leak. In response to the reviewer’s suggestion, we made a new figure with lower
magnification for better orientation. We would still like to show the leaking bleb in 
the revised manuscript because it is one of the most serious complications of 
MMC use. We have included it as figure 7D. However, we also added a
histological section of an intact MMC bleb (figure 7C) to the revised manuscript
as the reviewer suggested.
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